BioMed X Launches New T Cell Immunology Discovery Platform
A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for immunology discovery. Featured Image for BioMed X Institute HEIDELBERG, Germany, Feb. 14, 2023 (GLOBE NEWSWIRE) — BioMed X announced today the launch of its new immunology discovery platform that will […]